Manufacturer of Controlled Substances; Notice of Registration, 21917 [2011-9360]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 75 / Tuesday, April 19, 2011 / Notices
Drug
Schedule
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Oxymorphone (9652) ...................
Oxycodone (9143) ........................
II
II
II
Drug
Schedule
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
II
II
II
The company plans to manufacture
the above listed controlled substances in
bulk for distribution to its customers.
Drug codes 1100 (amphetamine) and
2550 (glutethimide) have been
withdrawn from the application for
registration at the request of the
company.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Siegfried (USA), Inc. to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Siegfried (USA), Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 11, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
I
I
The company plans to manufacture
small quantities of marihuana
derivatives for research purposes. In
reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidiol. In reference to
drug code 7370
(Tetrahydrocannabinols), the company
will manufacture a synthetic THC. No
other activity for this drug code is
authorized for this registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cayman Chemical Company to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Cayman Chemical
Company to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: April 11, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–9360 Filed 4–18–11; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2011–9361 Filed 4–18–11; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL TRANSPORTATION
SAFETY BOARD
DEPARTMENT OF JUSTICE
Sunshine Act Meeting
Drug Enforcement Administration
TIME AND DATE:
mstockstill on DSKH9S0YB1PROD with NOTICES
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated October 8, 2010, and
published in the Federal Register on
October 20, 2010, (75 FR 64744),
Cayman Chemical Company, 1180 East
Ellsworth Road, Ann Arbor, Michigan
48108, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
VerDate Mar<15>2010
16:19 Apr 18, 2011
Jkt 223001
9:30 a.m., Tuesday, April
26, 2011.
PLACE: NTSB Conference Center, 429
L’Enfant Plaza, SW., Washington, DC
20594.
STATUS: The ONE item is open to the
public.
MATTER TO BE CONSIDERED:
8093A Aviation Accident Report
Crash During Unstabilized Approach,
Empire Airlines Flight 8284, Avions de
´
Transport Regional Aerospatiale Alenia
ATR 42 320, N902FX, Lubbock, Texas,
January 27, 2009.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
21917
Telephone: (202)
314–6100.
The press and public may enter the
NTSB Conference Center one hour prior
to the meeting for set up and seating.
Individuals requesting specific
accommodations should contact
Rochelle Hall at (202) 314–6305 by
Friday, April 22, 2011.
The public may view the meeting via
a live or archived webcast by accessing
a link under ‘‘News & Events’’ on the
NTSB home page at https://
www.ntsb.gov.
NEWS MEDIA CONTACT:
FOR FURTHER INFORMATION CONTACT:
Candi Bing, (202) 314–6403 or by e-mail
at bingc@ntsb.gov.
Dated: April 15, 2011.
Candi R. Bing,
Federal Register Liaison Officer.
[FR Doc. 2011–9565 Filed 4–15–11; 4:15 pm]
BILLING CODE 7533–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2011–0082]
Biweekly Notice; Applications and
Amendments to Facility Operating
Licenses Involving No Significant
Hazards Considerations
I. Background
Pursuant to Section 189a.(2) of the
Atomic Energy Act of 1954, as amended
(the Act), the U.S. Nuclear Regulatory
Commission (the Commission or NRC)
is publishing this regular biweekly
notice. The Act requires the
Commission publish notice of any
amendments issued, or proposed to be
issued and grants the Commission the
authority to issue and make
immediately effective any amendment
to an operating license upon a
determination by the Commission that
such amendment involves no significant
hazards consideration, notwithstanding
the pendency before the Commission of
a request for a hearing from any person.
This biweekly notice includes all
notices of amendments issued, or
proposed to be issued from March 24,
2011, to April 6, 2011. The last biweekly
notice was published on April 5, 2011
(76 FR 18801).
Notice of Consideration of Issuance of
Amendments to Facility Operating
Licenses, Proposed No Significant
Hazards Consideration Determination,
and Opportunity for a Hearing
The Commission has made a
proposed determination that the
following amendment requests involve
no significant hazards consideration.
E:\FR\FM\19APN1.SGM
19APN1
]]>Agencies
[Federal Register Volume 76, Number 75 (Tuesday, April 19, 2011)]
[Notices]
[Page 21917]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9360]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 8, 2010, and published in the Federal
Register on October 20, 2010, (75 FR 64744), Cayman Chemical Company,
1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
------------------------------------------------------------------------
The company plans to manufacture small quantities of marihuana
derivatives for research purposes. In reference to drug code 7360
(Marihuana), the company plans to bulk manufacture cannabidiol. In
reference to drug code 7370 (Tetrahydrocannabinols), the company will
manufacture a synthetic THC. No other activity for this drug code is
authorized for this registration.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cayman Chemical Company to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cayman Chemical Company to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: April 11, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-9360 Filed 4-18-11; 8:45 am]
BILLING CODE 4410-09-P
